Home
Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.
Upcoming as of 2026-11-19 , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.
8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.
Add to your calendar (calendar.ics)
The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.
Upcoming
December 2027 346
2027-12
2027-12
Study completion Safest Choice of Antihypertensive Regimen for Postpartum Hypertension Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05551104
2027-12
Primary completion Safest Choice of Antihypertensive Regimen for Postpartum Hypertension Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05551104
2027-12
Study completion Improving CRT Outcome With Non-Invasive Cardiac Mapping Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05564793
2027-12
Primary completion Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05627375
2027-12
Study completion Acute Subcutaneous SemaglutidE in Acute Ischemic sTroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05630586
2027-12
2027-12
2027-12
Study completion Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05691244
2027-12
Study completion Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05844462
2027-12
Study completion The Danish Out-of-Hospital Cardiac Arrest Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05895838
2027-12
Study completion The THOR IDE Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05916950
2027-12
Primary completion First-line Cryoablation for Early Treatment of Persistent Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05939076
2027-12
Study completion ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05988411
2027-12
Primary completion ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05988411
2027-12
Study completion Safety and Effectiveness Study of SQ-Kyrin TMVr System for Functional Mitral Regurgitation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05988450
2027-12
2027-12
Study completion Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06093932
2027-12
2027-12
2027-12
Study completion Dapagliflozin in STEMI Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06174753
2027-12
Primary completion The STOP-MED CTRCD Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06183437
2027-12
Study completion REstoration of VItamin D in Pulmonary Arterial Hypertension Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06258850
2027-12
2027-12
Primary completion Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06365502
2027-12
Study completion Henagliflozin's Impact on Prediabetes Remission Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06448130
2027-12
Primary completion Regular Use of aPDT in the Management and Prevention of Periodontitis Symptoms in Diabetic Patients Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06486012
2027-12
Primary completion Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06499857
2027-12
Study completion Transcutaneous Electrical Acupoint Stimulation on Blood Pressure Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06537167
2027-12
Primary completion Transcutaneous Electrical Acupoint Stimulation on Blood Pressure Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06537167
2027-12
2027-12
Primary completion Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06548971
2027-12
2027-12
2027-12
2027-12
2027-12
2027-12
2027-12
Study completion Landiolol in Mitral Valve Surgery Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06793670
2027-12
2027-12
2027-12
Study completion Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06935591
2027-12
Primary completion SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06955260
2027-12
Study completion A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07021963
2027-12
Primary completion A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07021963
2027-12
Study completion Boston Medical Center Ultrasound Decongestion Study in Heart Failure Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07096726
2027-12
Primary completion Boston Medical Center Ultrasound Decongestion Study in Heart Failure Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07096726
2027-12
2027-12
2027-12
Primary completion A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV System Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07194265
2027-12
Study completion REVascularization In Large VEssel Occlusion for Acute Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07216170
2027-12
Primary completion REVascularization In Large VEssel Occlusion for Acute Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07216170
2027-12
2027-12
Primary completion A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07318155
2027-12
2027-12
Study completion Evaluation of iNstroke Aspiration Catheters for Thrombectomy: a Multi-center Prospective Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07376447
2027-12
2027-12
Primary completion T2D Intermittent Nonprescription Sensors for Informed Glucose Health Tracking Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07422831
2027-12
2027-12
Study completion TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07460960
2027-12
Primary completion TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07460960
2027-12
Study completion WEARABLE-BP: Wearable Everyday Automated Readings to Enable Assessment of Blood Pressure Control Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07523269
2027-12
Study completion Butylphthalide for Brain Edema After Endovascular Treatment Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07528456
2027-12
2027-12
Study completion Portable MRI for Pediatric Hypoxic Ischemic Brain Injury Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07577336
2027-12
Primary completion Portable MRI for Pediatric Hypoxic Ischemic Brain Injury Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07577336
2027-12
Study completion SURE-HF: Urinary Sodium-Guided Diuretic Therapy in Heart Failure Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07631780
2027-12
Primary completion SURE-HF: Urinary Sodium-Guided Diuretic Therapy in Heart Failure Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07631780
2027-12
2027-12
2027-12
2027-12
2027-12
Primary completion A Phase II Study of VB19055 in Uncontrolled or Resistant Hypertension Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07833098
2027-12
2027-12
Study completion Upper Extremity Orthoses Combined With Occupational Therapy in Subacute Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07864090
2027-12
Primary completion Upper Extremity Orthoses Combined With Occupational Therapy in Subacute Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07864090
2027-12
2027-12
2027-12
2027-12
2027-12-02
Primary completion Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07041281
2027-12-03
Study completion Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05591040
2027-12-03
Primary completion Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05591040
2027-12-04
2027-12-05
Study completion Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06096246
2027-12-06
Primary completion Study of ALXN2220 Versus Placebo in Adults With ATTR-CM Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06183931
2027-12-06
Study completion A Study of TAK-755 in Adults With Acute Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07392450
2027-12-06
Primary completion A Study of TAK-755 in Adults With Acute Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07392450
2027-12-12
Primary completion Venous Ethanol for Ventricular Tachycardia Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05511246
2027-12-12
Primary completion Edge-to-edge Mitral Valve Repair in ATTR-CM Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06075823
2027-12-12
Study completion ULTRA-EVOLUT RCT: A Comparison of Latest-Generation TAVR Valves Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07545369
2027-12-13
2027-12-15
Study completion Catheter Ablation Versus Radio-Ablation for Ventricular Tachycardia: a Randomized Controlled Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05047198
2027-12-15
Study completion Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06657209
2027-12-15
Primary completion Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06657209
2027-12-15
2027-12-15
Study completion PCSK9 Inhibitors in Acute Ischemic Stroke Patients Undergoing Endovascular Therapy Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07174375
2027-12-15
Primary completion PCSK9 Inhibitors in Acute Ischemic Stroke Patients Undergoing Endovascular Therapy Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07174375
2027-12-16
Primary completion Digoxin After Acute Heart Failure (DIG-DICA) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07321509
2027-12-17
Primary completion DCB vs. DES in Young STEMI Patients: The DCB-STEMI Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07229248
Overdue
The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.
2021-12-01
Study completion Bolus vs IVP (Intravenous Push) Diltiazem for Atrial Fibrillation or Flutter Registry record
Expected 2021-12-01; that period ended on 2021-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04141553
2021-12-01
Primary completion Bolus vs IVP (Intravenous Push) Diltiazem for Atrial Fibrillation or Flutter Registry record
Expected 2021-12-01; that period ended on 2021-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04141553
2021-12-01
Study completion Coronavirus (COVID-19) ACEi/ARB Investigation Registry record
Expected 2021-12-01; that period ended on 2021-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04330300
2021-12-01
Primary completion Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes Registry record
Expected 2021-12-01; that period ended on 2021-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04373967
2021-12-01
Primary completion Dapagliflozin And Pulmonary Artery Hemodynamics in Heart Failure With Reduced Ejection Fraction Patients With CardioMEMS® Registry record
Expected 2021-12-01; that period ended on 2021-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04570865
2021-12-01
Study completion Study on the Effectiveness and Safety of Shuxinin Injection in the Treatment of Acute Ischemic Stroke Registry record
Expected 2021-12-01; that period ended on 2021-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04950790
2021-12-01
Primary completion Study on the Effectiveness and Safety of Shuxinin Injection in the Treatment of Acute Ischemic Stroke Registry record
Expected 2021-12-01; that period ended on 2021-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04950790
2021-12-02
Study completion Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes Registry record
Expected 2021-12-02; that period ended on 2021-12-02.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04373967
2021-12-03
Primary completion Remote Monitoring System for Patients, Who Had Myocardial Infarction Registry record
Expected 2021-12-03; that period ended on 2021-12-03.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04424368
2021-12-15
Primary completion Safety and Efficacy of CVI-LM001 in Patients With Hypercholesterolemia Registry record
Expected 2021-12-15; that period ended on 2021-12-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04438096
2021-12-15
Study completion Comparative Evaluation of the McGrath Videolaryngoscope and the Direct Laryngoscopy for Tracheal Intubation in the Prehospital Setting Registry record
Expected 2021-12-15; that period ended on 2021-12-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04930419
2021-12-15
Primary completion Comparative Evaluation of the McGrath Videolaryngoscope and the Direct Laryngoscopy for Tracheal Intubation in the Prehospital Setting Registry record
Expected 2021-12-15; that period ended on 2021-12-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04930419
2021-12-20
Primary completion A Postmarket Clinical Trial for EXCROSSAL Stent in CAD Patients With 3-month DAPT or 12-month DAPT Registry record
Expected 2021-12-20; that period ended on 2021-12-20.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03716011
2021-12-23
Study completion rTMS in Aphasic Patients With Neuroimage Assessments Registry record
Expected 2021-12-23; that period ended on 2021-12-23.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03059225
2021-12-23
Primary completion rTMS in Aphasic Patients With Neuroimage Assessments Registry record
Expected 2021-12-23; that period ended on 2021-12-23.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03059225
2021-12-29
Study start The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients Registry record
Expected 2021-12-29; that period ended on 2021-12-29.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04365517
2021-12-30
Study completion Clinical Trial in Patients Who Have Suffered a Heart Attack and Who Have Undergone Catheterization Treated With Levosimendan Registry record
Expected 2021-12-30; that period ended on 2021-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03699215
2021-12-30
Study completion Evaluate the Transcatheter Artificial Aortic Valve and Transcatheter Artificial Heart Values Delivery System Registry record
Expected 2021-12-30; that period ended on 2021-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03788590
2021-12-30
Study completion LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention Registry record
Expected 2021-12-30; that period ended on 2021-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04060914
2021-12-30
Study completion Chinese Medicine Treat for Hypertensive Renal Injury Registry record
Expected 2021-12-30; that period ended on 2021-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04078711
2021-12-30
Study completion Early Treatment of ARNI on Myocardial Remodeling and Progress Registry record
Expected 2021-12-30; that period ended on 2021-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04342351
2021-12-30
Primary completion WJMSCs Anti-inflammatory Therapy in Coronary Artery Disease Registry record
Expected 2021-12-30; that period ended on 2021-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04551456
2021-12-30
Study completion The Evaluation of Consistency by Finger Stick Blood Glucose or Venous Blood Glucose of Flash Glucose Monitoring in Different Infiltration Time Registry record
Expected 2021-12-30; that period ended on 2021-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04797416
2021-12-30
Primary completion The Evaluation of Consistency by Finger Stick Blood Glucose or Venous Blood Glucose of Flash Glucose Monitoring in Different Infiltration Time Registry record
Expected 2021-12-30; that period ended on 2021-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04797416
2021-12
Study completion The Hemodynamic Response to Prolonged Dobutamine Infusion Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01042873
2021-12
Study start The Application of a Wireless Sensor Technology for Vital Statistics in CHILDREN AND ADULTS Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01845506
2021-12
Study completion Transcatheter Aortic Valve Replacement System Pivotal Trial Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02163850
2021-12-31
Study completion Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes Management Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02315287
2021-12-31
Primary completion Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes Management Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02315287
2021-12
Primary completion European Sleep Apnea and Sudden CArdiac Death ProjEct Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02506166
2021-12
Study completion Percutaneous Intervention Versus Surgery in the Treatment of Common Femoral Artery Lesions Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02517827
2021-12
Study completion Sleep Study-Guided Multidisciplinary Therapy for Patients Presenting With Acute Coronary Syndrome Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02599298
2021-12
Study completion Use of BVS in ST-segment Elevation Myocardial Infarction (STEMI): the BVS STEMI STRATEGY-IT Prospective Registry Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02601781
2021-12
Study completion Effect of Melatonin on Cardiometabolic Risk- FULL Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02681887
2021-12
Study completion Cilostazol Following Peripheral Endovascular Procedures Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02770274
2021-12
Primary completion Cilostazol Following Peripheral Endovascular Procedures Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02770274
2021-12
Primary completion PROTECT TAVI - Prospective Randomized Outcome Study in TAVI Patients Undergoing Periprocedural Embolic Cerebral Protection With the Sentinel™ Device Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02895737
2021-12-31
Primary completion Pupillometry in Horner's Syndrome Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02978079
2021-12
2021-12
Study completion Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03062397
2021-12-31
Primary completion Tenecteplase in Wake-up Ischaemic Stroke Trial Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03181360
2021-12-31
Study completion Early Management Strategies of Acute Heart Failure for Patients With NSTEMI Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03189901
2021-12-31
Primary completion Early Management Strategies of Acute Heart Failure for Patients With NSTEMI Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03189901
2021-12-31
Study completion Trial of EXenatide in Acute Ischaemic Stroke Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03287076
2021-12
2021-12-31
Study completion Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03418974
2021-12-31
Primary completion Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03418974
2021-12-31
Study start Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries. Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03423511
2021-12-31
Primary completion Multifactorial Intervention on Diabetes (MIDiab Study) Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03430284
2021-12-31
Study completion Aureva Transcranial Ultrasound Device With tPA in Patients With Acute Ischemic Stroke Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03519737
2021-12
Study completion HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03550859
2021-12
Primary completion HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03550859
2021-12-31
Study completion Pentoxifylline Effect in Patients With Diabetic Nephropathy.(PENFOSIDINE STUDY) Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03664414
2021-12
Primary completion MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE-MR Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03705312
2021-12-31
Study completion Effectiveness of a Repetitive Use of 24-hour Levosimendan Infusions in Patients With Severe Systolic Heart Failure in Order to Prevent Rehospitalizations Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03764722
2021-12-31
Primary completion Effectiveness of a Repetitive Use of 24-hour Levosimendan Infusions in Patients With Severe Systolic Heart Failure in Order to Prevent Rehospitalizations Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03764722
2021-12
Study completion Can Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy (DAPT) Improve Thrombotic Status in Acute Coronray Syndrome (ACS) ACS Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03775746
2021-12
Primary completion Can Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy (DAPT) Improve Thrombotic Status in Acute Coronray Syndrome (ACS) ACS Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03775746
2021-12
Study completion Early Initiation of Low Dose Tirofiban for PPCI in STEMI Patients. Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03797729
2021-12-31
Study completion CUHK Jockey Club HOPE 4 Care Programme - Ankle Robot Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03808428
2021-12-31
Primary completion CUHK Jockey Club HOPE 4 Care Programme - Ankle Robot Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03808428
2021-12
Primary completion Clinical Investigation of ENO/TEO/OTO Pacing System Under MRI Environment Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03811691
2021-12
Primary completion rTMS and Robotic Gait Training in Patients With Stroke Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03817385
2021-12-31
Study completion CUHK Jockey Club HOPE 4 Care Programme - FES Bike Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03848624
2021-12-31
Primary completion CUHK Jockey Club HOPE 4 Care Programme - FES Bike Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03848624
2021-12-31
Study completion Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03851432
2021-12-31
Study completion Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA (FAVORITE) Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03891277
2021-12-31
Primary completion Atrial Sensing Capability for Better Detection of Atrial Fibrillation Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03932604
2021-12
Study completion A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03950843
2021-12-31
Study completion Impact of Lipoic Acid Use on Stroke Outcome After Reperfusion Therapy in Patients With Diabetes (IMPORTANT) Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04041167
2021-12-31
Study completion Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04146155
2021-12-31
Primary completion Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04146155
2021-12
Study completion Xingnaojing for Mild-to-severe Acute Ischemic Stroke Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04150835
2021-12
Primary completion Xingnaojing for Mild-to-severe Acute Ischemic Stroke Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04150835
2021-12-31
Primary completion New Designed ePTFE Valved Conduits for Surgical Reconstruction of Right-ventricular Outflow Tract Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04152967
2021-12-31
Study completion Digital Integrated Healthcare Platform in Patients With Type 2 Diabetes Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04161170
2021-12
Study completion Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04169269
2021-12
Study completion Influence of the PEPA Membrane on the Undernutrition Syndrome Inflammation in Chronic Hemodialysis Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04185571
2021-12
Study completion Safety and Efficacy of the Tong-Fu-Xing-Shen Herbal Formula for Stroke-Associated Pneumonia Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04275219
2021-12
Primary completion Safety and Efficacy of the Tong-Fu-Xing-Shen Herbal Formula for Stroke-Associated Pneumonia Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04275219
2021-12-31
Primary completion Wearable Devices for Secondary Prevention of Ischemic Stroke Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04282993
2021-12
Study completion Safety and Efficacy of Samsung GEMS-H Device Training in Sub-Acute and Chronic Stroke Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04285060
2021-12
Study completion Use of ReDS Technology in Patients With Acute Heart Failure Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04305717
2021-12
Primary completion Use of ReDS Technology in Patients With Acute Heart Failure Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04305717
2021-12
Study completion Robot-assisted Therapy Combined With Mirror Priming in Upper Limb Training in Stroke Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04326140
2021-12
Primary completion Robot-assisted Therapy Combined With Mirror Priming in Upper Limb Training in Stroke Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04326140
2021-12-31
Primary completion Implementing Standards of Care for Heart Failure Patients in General Practice - A Regional Disease Management Program Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04334447
2021-12-31
Study completion Remote Monitoring System for Patients, Who Had Myocardial Infarction Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04424368
2021-12
Primary completion Comparative Analysis in Detection of Atrial Arrhythmia and ECG Quality in Three Different Insertable Cardiac Monitors Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04471584
2021-12-31
Study completion VitaFlow™ Transcatheter Aortic Valve System Pre-market Trial Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04655742
2021-12
Study completion Safety and Efficacy Study of Clevidipine Butyrate Injection in Hypertensive Emergencies Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04670809
2021-12-31
Primary completion Natural History of COVID-19-Related Atrial Fibrillation Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04830774
2021-12
Study start Cardiovascular Diseases and Diabetes Prevention Programme in Metabolic Syndrome (CDPP) Registry record
Expected 2021-12; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05105321
2021-12-31
Study start Folic Acid and Intensive Antihypertensive Therapy for Hypertension With CSVD Registry record
Expected 2021-12-31; that period ended on 2021-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05169021
2022-01-01
Study start IABP In AMI Patients With SCAI-B Study Registry record
Expected 2022-01-01; that period ended on 2022-01-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04989777
2022-01-01
2022-01-01
Study start The Effects of TMZ on Diabetic Nephropathy Registry record
Expected 2022-01-01; that period ended on 2022-01-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05147194
2022-01-05
Study completion COVID-19 Lockdown Related Telemedicine for Type 2 Diabetes Registry record
Expected 2022-01-05; that period ended on 2022-01-05.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04723550
2022-01-10
2022-01-12